# A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

> **NCT03006848** · PHASE2 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 19 (actual)

## Conditions studied

- Osteosarcoma

## Interventions

- **DRUG:** Avelumab
- **OTHER:** Questionnaires

## Key facts

- **NCT ID:** NCT03006848
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-16
- **Primary completion:** 2020-03-18
- **Final completion:** 2020-03-18
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2026-02-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006848, "A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03006848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*